Ares Capital Corp
NASDAQ:ARCC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
19.55
21.72
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Good afternoon. Welcome to the Ares Capital Corporation Third Quarter ended September 30th, 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. As a reminder, this conference is being recorded on Tuesday, October 26, 2021. I will now turn the conference over to Mr. John Stilmar, Managing Director of Ares Investor Relations.
Thank you. Let me start with some important reminders. Comments made during the course of this conference call and webcast and the accompanying documents contain forward-looking statements and are subject to risks and uncertainties. The Company's actual results could differ materially from those expressed in such forward-looking statements for any reason, including those listed in its SEC filings. Aries Capital Corporation assumes no obligation to update any such forward-looking statement.
Please also note the past performance or market information is not a guarantee of future results. During this conference call, the Company may discuss certain non-GAAP financial measures as defined by SEC Regulation G, such as core earnings per share or core EPS. The Company believes that core EPS useful information to investors regarding financial performance because it is one method the Company uses to measure its financial condition and results of operations. A reconciliation of core EPS, the -- to the net per-share increase or decrease in stockholders equity resulting from operations, the most directly comparable GAAP financial measure can be found in the accompanying slide presentation for this call. In addition, reconciliation of these measures may also be found in our earnings release filed this morning with the SEC on Form 8-K.
Certain information discussed in this conference call and the accompanying slide presentation, including information related to portfolio companies, was derived from third-party sources and has not been independently verified. And accordingly, the Company makes no representation or warranty with respect to this information. The Company's third quarter ended September 30th, 2021 earnings presentation can be found on the Company's website at www. arescapitalcorp.com, by clicking on the "Third Quarter of 2021 Earnings Presentation" link on the homepage of the Investor Resources section, Ares Capital Corporation 's earnings release and 10-K are also available. I will now turn the call over to Kipp DeVeer, Ares Capital Corporation Chief Executive Officer.
Thanks a lot, John. Hello, everyone, and thank you for joining the call today. I'm here with our co-Presidents, Mitch Goldstein and Michael Smith; our Chief Financial Officer, Penny Role; and several other members of the management team. I will begin by providing some third quarter highlights and then discuss the current market and the Company's positioning. This morning, we reported Third Quarter core earnings of $0.47 per share, up from $0.39 per share a year ago, and well ahead of our $0.41 per share dividend.
Our third quarter GAAP earnings per share of $0.73 included a $150 million of net realized and unrealized gains. Which drove our net asset value to a new record of $18.52 per share. Our NAV is now about a $1.20 per share higher, than the NAV pre -pandemic. With this rising NAV, we've generated a $110 million of realized gains in excess of losses since the onset of the pandemic. Which I believe is a real achievement for a debt oriented portfolio, and is worth calling out. This continued increase in NAV demonstrates not only the quality of our underwriting, and the benefits of our approach to portfolio construction.
But also, the strength of our risk management efforts and our portfolio management team. These gains add to our industry-leading track record. The Company has now generated over a billion dollars in net realized gains since our IPO in 2004. We believe we are one of the few business development companies, that has demonstrated an ability to pay a stable dividend, while growing our NAV over an extended period of time, and through multiple credit cycles. In terms of the current market, we believe we are benefiting from an expanding opportunity set, and we believe we've increased our market share, in this large and growing industry. The U.S.
economy is experiencing well above average economic growth, and this remains a positive driver of transaction activity. Companies and sponsors are increasingly seeking growth capital, to support the execution of Organic and M&A driven business plans. Additionally, private capital solutions, are now increasingly accepted by larger companies. Who see value in our flexible capital, partnership approach, and our ability to provide certainty of close. As these market trends accelerate, we've seen the size of our portfolio companies grow. And today, the weighted average EBITDA of our portfolio companies has increased to $157 million compared to 67 million just 5 years ago.
We believe our Company is now operating with a wider fairway for deal opportunities and an expanding market for direct lenders in the U.S. The Company's exceptional team, scale and market tenure, coupled with the many platform advantages we can harness at Ares, have all permitted us to expand our share and what we believe to be a $1.5 trillion addressable market. As evidenced of this trend, our pipeline of reviewed transactions has increased almost four times faster, than Refinitivs view of the reported middle market since 2019. In order to achieve this market share growth, we continue to build upon on our relationships with sponsors, and middle-market companies. We believe our track record of working with private equity sponsors, during our 17 years as a public Company is unmatched. We continue to benefit from the continued growth in private equity. We've closed transactions with more than 400 sponsors, or continuing to expand our leading roster of private equity relationships.
With over 15% of the deals completed this quarter being with new sponsors. Beyond our sponsor relationships, we continue to develop our coverage of non-sponsored transactions. Over the past 5 years, we focused more intently on expanding these capabilities, and now have dedicated specialized teams in software, healthcare services, financial services, and sports media and entertainment, all aimed at going direct to companies seeking financing. We're seeing these focused industry groups contribute meaningfully to the growth of our non-sponsored business, and over the past 4 quarters, our non-sponsored total commitments grew over 30% when compared to the full-year 2019. In addition to these sourcing advantages, our team continues to focus on the existing portfolio, and robust risk management. Our portfolio companies are generally demonstrating strong underlying financial performance.
In the third quarter, the weighted average annual EBITDA growth rate of our portfolio companies, increased 13%. More than double the conference boards expected GDP growth for 2021. The strong growth and profitability of portfolio companies, reflects our longstanding focus on selecting high free cash flow companies, in defensive industries, with relatively inelastic demand for their products and services. For example, our 3 largest industries: software and services, healthcare services, and commercial and professional services, which represent about 40% of the portfolio today, are demonstrating 30% faster EBITDA growth on average than the overall portfolio as a whole. We believe this orientation to defensive industries and downside protection has positioned our portfolio away from segments of the economy that are likely to be negatively impacted by commodity inflation and the current supply chain disruptions that we are witnessing generally. With strong overall portfolio credit metrics, it's also worth noting that our non-accrual rates at cost declined this quarter and are now below our historical average. With that, let me turn the call over to Penny to provide more details on our third quarter results and some updates on the Balance Sheet.
Thanks Kipp. Good afternoon everyone. Our core earnings per share of $0.47 for the Third Quarter of 2021 were primarily driven from higher recurring interest and dividend income, due to our net portfolio growth in the past quarter, as well as capital structuring service fees from a continued strong level of originations. Our GAAP earnings per share was $0.73 for the third quarter of 2021, including net realized and unrealized gains of $0.33 per share.
The net unrealized gains on investments for the quarter primarily reflect performance improvement in the companies in our portfolio, continued tightening of credit spreads on our loan book, and improved valuations of our equity investments relative to the end of the previous quarter. At September 30, 2021, our stockholders equity grew to $8.5 billion, resulting in a record net asset value per share of $18.52. An Increase of 2% from a quarter ago and over 12% since the third quarter of 2020. Our total portfolio at fair value, at the end of the quarter was $17.7 billion, and we had total assets of 19.2 billion.
As of September 30,2021, the weighted average yield on our debt and other income producing securities at amortized costs was 8.6%, and the weighted average yield on total investments at amortized costs was 7.7%, as compared to 8.8% and 7.7% respectively at June 30, 2021. At September 30, 2021, 80% of our total portfolio at fair value was in floating rate investments. Additionally, excluding our investment in the SDLP certificates, 91% of the remaining floating-rate investments had an average LIBOR Floor of approximately 1%, which is well above today's current 1 and 3 month LIBOR rates. Shifting to our capitalization and liquidity, we had another active quarter focused on raising additional capital to help fund the continued growth of our business.
During the quarter, we took advantage of a drop in treasury rates along with improved spreads, and reopened our existing 2178 June 2020 notes. We issued an additional $400 million at a premium, resulting in an effective yield to maturity on the incremental borrowings of 2.44%, which was 43.5 basis points tighter than the existing coupon. We have been active issuers in the investment-grade term debt market during this period of historically low treasury rates. This environment, along with improving spreads and the ability to repay higher rate debt, has allowed us to reduce the weighted average stated interest rate on our outstanding unsecured term debt by 68 basis points since December 31st 2019. It is also worth noting that we believe our approximately $1 billion of unsecured term debt maturities in early 2022 with a weighted average coupon of 3.7% represents an opportunity to further reduce our aggregate weighted average cost of borrowing.
During the third quarter, we also assertively issued a modest amount of equity capital through the combination of the secondary offering, as well as issuances from our ATM program to support the investing opportunities that Kipp mentioned in his opening remarks. Considering these capital raises, we ended the third quarter with over $6 billion of total available liquidity. Our debt-to-equity ratio net of available cash of over $1 billion was 1.04 times at September 30, 2021 down from 1.12 times at the end of the second quarter. While our leverage ratio overtime will vary depending on activity levels.
We remain committed to operating within our stated target leverage range of 0.9 to 1.25 times. Overall, we continue to believe our strong balance sheet and financial position remains one of our most significant competitive advantages and enables us to actively invest in all market environments. Before I conclude, I wanted to mention that we have completed our prior year tax return and can now report a final undistributed taxable income spillover from 2020 of $1.06 per share. We continue to believe that having a strong and meaningful undistributed spillover supports our goal of maintaining a study dividend through varying market conditions and sets us apart from many other BDC s. With respect to the fourth quarter 2021 dividend of $0.41 per share. It is payable on December 30, 2021 to stockholders of record on December 15th, 2021. I will now turn the call over to Mitch to walk through our investment and realization activities for the quarter.
Thanks, Penny, as Michael Smith and I do every quarter, I will focus on providing more details on our investment activity and portfolio performance for the third quarter, including some thoughts on drivers of our net realized gain performance. I will then conclude with an update on our post-quarter-end activity, backlog, and pipeline. Starting with our investing activity, we had a very active quarter with 3.1 billion of new commitments, 70% higher than our pre - Covid 2019 quarterly average, and resulting in 9.7 billion, of total commitments year-to-date through September. During the third quarter, we invested in 47 companies across 19 distinct industries, with a weighted average EBITDA of approximately $100 million.
Although the weighted average EBITDA of our portfolio has grown over the past couple of years. It should be noted the EBITDA of the companies we finance at this quarter, range from less than 15 million to more than $500 million. This range should provide some insight into the breadth of our sourcing capabilities. We continue to see compelling value in our historic core middle markets and are finding interesting businesses with strong growth prospects that we believe will have additional financing needs as they grow. One of our distinct advantages in today's active deal environment is our position of incumbency with more than 370 different portfolio companies.
Incumbency enables us to support the growth of businesses that we know well and in turn provides distinct informational and investing advantages. In highly competitive markets, you will often see us focus to a greater extent on financing incumbent borrowers. Similar to last quarter where the majority of our investments where to existing borrowers, 60% of our third quarter transactions, were with incumbent borrowers. As many of our portfolio companies were involved in strategic M&A, to support their growth prospects. We believe our portfolio remains attractively positioned.
It highly diversified across industries, sponsors, and asset classes with an average position size of only 0.3%. Our portfolio also continues to skew towards senior positions, as 86% of the loans we committed to year-to-date, were senior secured. By investing in senior positions and maintaining a focus on resilient industries, and market-leading companies, we've been able to construct a portfolio with significant downside protection. For example, our debt portfolios weighted average loan-to-value was approximately 43% at the end of the third quarter, well below the mid 50s levels seen in prior to the pandemic. Another measure of the strong overall health of our portfolio is our non-accrual rate at cost, which declined 120 basis points since last quarter to 1.7% and is now below pre -pandemic levels.
This quarter, 4 companies will remove from non-accrual, and there were no new additions. In short, we feel really good about the overall health and credit quality of our portfolio. I would now like to discuss some of the drivers of our long-term strong credit performance. Over the years, we've often talked about the power of the Ares platform, in driving results for RCC. These advantages include our strong research teams across our credit platform, with over 70 professionals covering more than 60 industries.
Our access to robust deal flow, or our ability to gain insight from a broad set of C-suite executives. Importantly, we believe that each of our investment groups at Ares, joins ARCC in benefiting from being part of the broader platform. Today, I'd like to quickly highlight another one of those platform advantages. Our portfolio management team, Kipp alluded to this earlier, but it is a team of 28 season individuals, which we believe is larger than the entire teams of some of our competitors and is responsible for monitoring our credits, providing portfolio of Company evaluation analysis each quarter, and helping companies that may experience difficulties. This quarter, our portfolio management team, leveraging the broader Ares platform, helped build upon ARCC's long track record of net realized gains, which in turn contributed to our continued growth in NAV.
Specifically, ARCC generated a realized gain of over $100 million on an investment where we needed to take an active role in managing the business and supporting the strategic direction of the Company over the past several years. As Kipp mentioned, this type of outcome is not unique, as we have generated over $380 million of restructuring gains since our IPO. Strong NAV performance was also helped by working with our portfolio companies and capitalizing on the strength of the economy and the financing markets. In multiple instances this quarter, debt positions that were held at discounts to par just last quarter, along with some that had been on non-accrual in the past, where we pay that part.
And now we will finish with a brief update on our post-quarter and investment activity and pipeline. From October 1st through October 20th, 2021, we made new investment commitments totaling 1.5 billion, of which 1.3 billion were funded. We exited or were repaid on 415 million of investment commitments, generating approximately 5 million of net realized gains on exits. As of October 20th, our backlog and pipeline stood at roughly 1.9 billion, and 149 billion respectively. Our backlog contains investments lever subject to approvals and documentation and may not close, or we may sell a portion of these investments post-closing. I will now turn the call back over to Kipp for some closing remarks.
Thanks, Mitch. I'll close by saying we believe the Company is in an excellent position today. The advantages provided by our scale, our platform, the strong balance sheet, and our highly experienced team continue to enable us to drive attractive financial results for our investors. With our leading market presence in the growing market opportunity, we're excited about our future growth prospects. Our industry continues to grow, and our leadership position in it is getting more embedded. We deeply appreciate the continued support for our Company, and with that, Operator, we'd be happy to open the line for questions.
Thank you. At this time if you would like to ask a question, [Operator's instruction]. Please note, as a courtesy to those who may wish to ask a question, please limit yourself to one question and a single follow-up. If you have additional questions, you may re-enter the queue. The investor relations team will be unveiled, will be available to address any further questions at the conclusion of today's call. Our first question today is from Ryan Lynch with KBW. Please go ahead.
Good afternoon. First question I had. If I look at your overall origination commitment values, so far, year-to-date, including the October data that you provide, you guys are well over $10 billion of overall commitments. Which is significantly above the 2018 and 2019 levels. So my question is, how much of this is a function of a visually strong volumes, or function of pent up demand and activity from kind of the light levels, and the slowdown we had in 2020, or how much is it? Other this is really from the changing landscape that we're seeing in the direct lending market and really the proliferation of these large [Indiscernible] deal that you guys seem to be taking a lot of share in? And how really sustainable is $10 plus billion of commitment volumes at ARCC going forward?
Yeah, Ryan, it's Kipp. Hey, thanks for the question. It's a good one. It's obviously one that we're asking ourselves about and without the crystal ball, don't know. I think it's both for the time being, Ryan. We definitely think that there's a fair amount of pent-up demand coming out of COVID. Low rates persist and the economy remains strong, so this will be a record origination here. Our view of the fourth quarter is looking very busy.
In the first half of 2022, I think will continue to be busy too beyond that, it's really difficult to forecast. But we do see this underlying trend that you're referencing, which is we believe increased acceptance of direct lenders and private capital versus the public markets. Frankly, excitement about not even acceptance of and we see the industry taking some share and we think that we're taking some share within the industry as the largest player. So it's going to be difficult to see, but that'll be the question I think for 22 and beyond, right?
Okay. That's helpful Color. Penny, maybe just one for you as my follow-up. You mentioned some of the primary drivers of the gains, that caused your portfolio to be written up this quarter, performance improvements, tighter spreads, and an improvement evaluations for some of your equity investments. Could you maybe just give a ballpark estimate of the overall net gains that you guys had in your portfolio? How much of that was driven by write-offs in fair value of your equity portfolio?
Sure. Yes, if you just look at this quarter, what drove the fair value improvement, the majority of it came from the equity portfolio, given these higher market multiples. So if you'd look at the kind of per share impact of I think $0.33 of net gains for the quarter is about $0.19 coming from equity.
Got it. Appreciate the time today, and nice quarter, guys.
Thanks, Ry.
The next question comes from Finian O'Shea with Wells Fargo Securities. Please go ahead.
Hi, everyone, and thank you. Just to follow-up on Ryan's topic there on sort of the expanded market opportunity, in some of these larger names. How are you thinking of growing the SDLP? Given it was designed for that kind of opportunity, you still have pretty ample runway in the non-qualifying bucket.
I think we've got a whole handful of options there. I appreciate the question. Obviously, SDLP is a lever that we can pull additional growth at Ivy Hill. It's something that we can pursue as well as, obviously, those are the two big components of our 30% allowance today. But it's not going to be as you say, doing these larger deals is not reliant -- we're not reliant on SDLP. Ryan, we're able to do a lot of these larger unit tranches and participate in substantial transactions with the capital base.
So all we try to refer back to is the fact that we think that this market has grown a lot in the last 7 or 8 years, our Company in terms of assets, has been reasonably stable. So folks said, why raise equity in the past? The reason that we raised the equity is, we thought it was good to help grow the Company's earnings, and obviously that it was good for existing shareholders in new shareholders alike. But I don't think of to your question, is SDLP being tremendously impactful about, in regards to our ability to keep growing the Company.
Sure. Thank you, and just a follow-up, I guess, market question. With your comments on the larger addressable market. Is there -- Does that include these very large privates to syndicalism insurance type. What's the balance between that if any and just an expanded core middle-market with all the new private equity money that would be more likely to provide you more BDC investments type yields? Just color on what the market growth -- how much of it is providing the right yield for the BDC industry?
Yeah. I mean, what we've said, we don't feel that we're sacrificing any return, doing these larger transactions, right? We've actually said we think that there's a little bit of better risk reward frankly in these larger deals than what we've seen in, historically, the smaller middle-market businesses that we financed over the years. And I think to answer your question, just because of the law of large numbers, I think a lot of the market growth has occurred because some of these larger transactions are now of interest to larger private equity funds.
And they're going direct to private capital sources instead of doing syndicated deals, often willing to pay a higher price in the private markets than they are in what would potentially be a public market alternative just to de -risk and to know who their capital partner is and have support for ongoing growth in the future. So I think it's mostly -- to try to answer your question, I think it's a little bit of everything, but I think it's mostly these larger transactions that are driving the market growth.
Got it. Thanks so much, and congrats on the quarter.
Hey, thanks. Thanks for your questions.
The next question comes from Devin Ryan with JMP Securities. Please go ahead.
Hi, good afternoon. This is [inaudible 00:29:00] for Devin. First question, how did environment and its impact on deal pricing has been a prominent conversation over the last few quarters, are you still seeing continued downward pressure, or has that began to normalize a bit?
Yes. I mean, you'll see the yield on our investments have come down over the last few quarters. I think that's typical. Frankly, with a better economic backdrop, the competition really isn't any different. I think the competition is just alive again as COVID at least slowed down and become less of a risk and a lot of the economies reopen. So with that, you'd expect, with such good positive backdrop on the economic front and obviously we talked about how good our portfolio looks in terms of the growth and also the decline in non-accruals. I think you're seeing folks that are willing to take slightly lower yields. Interestingly though, that's coming with substantially higher purchase prices in most of the private equity transactions that we're seeing. So we don't feel that we have less attractive proposition with a slightly lower yield in the portfolio. I think it's just natural, as we come through the cycle here.
Okay. I appreciate the color there, Kipp. Then second question. Looking at [Indiscernible] Net Income that increased this quarter to 14.5% of total interest income. I would assume that's driven by recent investments that were structured with uptick component rather than the result of temporary concessions with borrowers. Just curious if that's correct.
That is generally correct. I mean, most of it's a little bit influenced by obviously the significant repayment that we had. in a Company called OTG. That was a portion of it marked below par, or there were some pick concessions there, and we've got repaid on all of our debt investments at par. Which was a great outcome for us, and we have a remaining equity piece outstanding. So there is a little bit of funniness in the numbers this quarter, but most of the PIC is coming through some of the larger junior capital investments that we've made, and that whole concept of providing concessions, i.e. Pay and pick instead of cash for the time being, is largely behind us. It's COVID, but luckily has kind of come through the portfolio for the most part.
Okay. That makes sense. Thanks for taking my questions, and congratulations on a strong quarter.
Thanks very much. Appreciate the questions.
The next question comes from John Hecht, Jefferies, please go ahead.
Hey, guys. Good morning. Thanks for taking my question. Actually, good afternoon, your time. Just because interest rates are so Top [Indiscernible], I'm wondering, and inflation as well. I'm wondering, do you guys -- can you remind us how interest rate sensitive you are? And second, do you have any thoughts about potential inflationary pressures and how, how it affects that portfolio that you guys have?
Sure. I'm happy to answer that. So generally to go back up to 50,000 feet, we do try to remind folks, obviously and most of our shareholders that owned lots of different financial stocks, we're probably one of the least interest rate sensitive stocks around, because we obviously run with materially lower leverage than most financial institutions, right? So as we mentioned, our leverage tends to run somewhere between where we are today, 1, 1.25. And on the asset side, all of our assets -- most of our assets, I should say, are floating rate, so we're positively inclined toward rates going up.
We lose a little bit on the financing side, but again, it's immaterial. So for us, rates isn't a huge consideration. Just as a reminder too, we publish in our filings just disclosure around what modest increases or decreases in LIBOR would do to the balance sheet, and you'll see that anything de minimis for the time being, either up and down, has very little impact on our earnings. So that's sort of where we cover off on the first point. Look, in terms of inflation and everything that we're reading in the newspapers about supply disruptions, we think they're real for sure and we've gone in and spend a lot of time scrubbing the existing portfolio in places where they would be most impactful.
The good news is we're [Indiscernible] in a lot of these sectors and companies that I think would be most touched by that. If you look at our largest industries, it tends to be things like software and services and healthcare services and all of that, things that really have not been impacted in any way, shape, or form. But we're definitely doing a fair amount of work because we're seeing supply disruptions and companies that are obviously trying to get parts over. We're trying to get goods over, and that has for sure an inflationary effect.
For the most part our companies are underwritten, to really try to waive those in that have good pricing power. We have very little exposure to industries and the companies, where there's no pricing power. But I think look, because you read the headlines, right John? Lots and lots of CEOs out there saying yes, we're raising prices. We're seeing supply disruptions, we're seeing input cost inflation, and our turn is to obviously turnaround and pass that onto the consumer, of whatever those goods or services are so. I think it's real, and I think it's going to last a while, but I do think that were underexposed, and not as impacted as a whole host of others.
Okay. I appreciate the color and the thoughts. You also mentioned a greater percentage of non-sponsored activity. I'm wondering is there generally different characteristic, of a non-sponsored transaction from a sponsored transaction?
Yes, I would say look the convention that to keep it really simple. Because in these non-sponsored deals, you're going in as really the only institutional capital, in a Company where there's no private equity. So it can be a combination of debt and equity that we're investing in these businesses.
They tend to be owned by founders, families, entrepreneurs that aren't in the, I want to sell the private equity, or I want to sell the my competitor and exit, but they're looking for some sort of transformational capital. So typically, they command much, much lower leverage ratios. They typically come with higher returns, both in terms of deal than off-net equity participation. But we think that's warranted.
I mean, we've been doing on sponsored deals for a long time, and they inherently tend to be a little bit riskier third quarter. But if you're selective and you're good at sourcing, and obviously underwriting and managing those companies and those relationships, that can be very high reward too. So in business 15 years ago was so private equity oriented and that -- that's not to say that we didn't do sponsored -- non-sponsored transactions, but I think for us just to continue looking at growth opportunities for the Company. Our ability to bring on more industry expertise and more sourcing, to go direct with something that was important, and we finally said, we're going to do that with standalone teams, probably four or five years ago. We just haven't spent a whole lot of time talking about it, but it's something that we, are more active doing today than I think we were five-years ago.
About 15% of the portfolio today, John, is non-sponsored for you and for others out there, so.
Okay. Great, thanks.
You're welcome. Thanks for the questions.
[Operator Instructions]. The next question comes from Robert Dodd with Raymond James. Please go ahead.
Hi. Good afternoon, everyone. Yeah, and congratulations on the quarter and the Balance Sheet. Actually, to follow up on John 's question since he jumped on it. On the non-sponsored, I mean, to your point, Kipp, it's something you've talked about a lot. 15% of the portfolio is get -- material, right? So on, on that, when you talked about it was 30% increase in deal volume kind of last four quarters versus 2019. Obviously, your overall increase in deal volume of that periods is roughly double that. I mean, obviously market activity is really hard. So, I mean, should we expect that on sponsored to actually grow? Or is it just a niche 15% of the portfolio is not small niche, but is it just a niche area for you or do you expect to actually grow, that maybe if the overall just larger into the market.
I mean, I would guess because of the resources that we've invested, obviously that it would grow. We'd like it to grow whatever be 50% of our deal flow of 50% of the portfolio, I don't think so. Right good, good growth for us just as I approximate it could be, I don't know if the 20, 25% of the portfolio. But really all we're trying to do is expand the origination, and obviously this will expand the opportunity set.
Got it. Then just following up on that, that's my follow-up question. You mentioned the higher returns on what -- which makes sense high risk for high return. What would you -- how would you characterize the opportunity in the non-sponsored segment with income -- how does that work with incumbency? Because you also talked about incumbency advantages and etc., which obviously, when there's a sponsor process and those things, obviously a change hands somewhat regularly, if it's a sponsor-backed business. On the non-sponsored side, do they -- does incumbency come into play and that's one of the tools that has been an advantage in other areas that you've grown into? How does those two things kind of --
I actually think the -- yes, I actually think to your point about private equity having the need to sell something after three to five-years. That inevitably creates the opportunity for somebody new, a new owner on a business. But to answer your question quickly and specifically, I think the incumbency advantage in these non-sponsored transactions as much, much higher. So we're selling ourselves as a capital provider and as a partner to these families, operators, entrepreneurs, etc.
And once they choose us and they see the flexibility of our capital and the ability for us to scale with them, they -- they tend to like us as partners and see us as being able to add quite a lot of value to their businesses. So I could rattle through a handful of different non-sponsored deals, that we've been in for ten plus years, right? It's just a different, it's a different relationship because again, at the end of the day, your counter party is somebody who really doesn't want to do a change of control transaction. They just want to continue maybe doing acquisitions, building plants, building out services capabilities, etc., they tend to be longer.
I appreciate it. Thank you.
Thanks very much.
The next question comes from Melissa Lugo with JPMorgan. Please go ahead.
Good afternoon, everyone. Thanks for taking my questions. Wanted to follow up on the questions around moving up market, wondering if the portfolio floors still in the a 100 bips range. Generally as you do these larger deals, are you seeing any pressure on those floor rates?
I'm sorry, Melissa. Are we seeing pressure on what?
On the floor rate, particularly, for the larger Company deals that you're doing.
I mean, not really Florida on some on some of the deals. They've drifted from 0.75 basis points for not really seeing any pressure beyond that.
Okay. so as we think about -- I take your point about the -- actually appreciating the better risk adjusted returns that you're seeing with some of those larger deals. And just in terms of sort of portfolio yield and compression, is that something that we should expect to persist, particularly as the markets expands into -- and private capital becomes more accepted with these larger companies?
I think that's the $64,000 question that everybody's asking, right? So our team has been doing this for a really long time, as you know, both at banks, and then obviously at areas for the last 17 years, and I would tell you that over those 17 years, the markets institutionalized, and returns have generally come down as a whole. They obviously spiked back up when capital is less available and when competition is less frequent and all of that.
But the one thing that puts a little bit of a floor on yield is the fact that most of the folks running direct lending money in private capital these days don't use a lot of leverage, right? So the syndicated market, for instance in loans, is supported by highly levered CLO buyers, that are very dependent on their cost of capital, and the amount of leverage they can get, i.e. what's AAA pricing, is there CLO levered 8 times or 14 times. That dynamic doesn't exist so much in direct lending. So we do think there's a bit of a floor, and I'm hopeful that work. We're kind of scratching that floor right now. Base pricing for unit ranches these days is libor 550, libor 600 for really good companies, we haven't seen it drift much lower than that. Hopefully no one breaks a back, you know what I mean?
Got it. Thanks Kipp.
Yeah. You're welcome. Thanks for the question.
This concludes our question-and-answer session. I would like to turn the conference back over to Mr. Kipp DeVeer for any closing remarks.
No. I don't have any other than to just say thanks for all the great questions and we will follow up with you all after the call and into next quarter. Appreciate the time.
Ladies and gentlemen, this concludes our conference call for today. [Operator Instructions] [Operator Instructions] An archived replay will also be available on a webcast link located on the homepage of the Investor Relations section of Ares Capital website. Thank you for attending today's presentation. You may now disconnect.